Drug General Information
Drug ID
D0R0EF
Former ID
DIB003042
Drug Name
AZD-7268
Synonyms
Enkephalinergic receptor modulator (oral, depression, anxiety), AstraZeneca
Drug Type
Small molecular drug
Indication Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] Phase 2 [522867], [542769]
Company
AstraZeneca plc
Structure
Download
2D MOL
Formula
C29H30N4O2S
InChI
InChI=1S/C29H30N4O2S/c1-32(16-17-34)29(35)24-9-7-21(8-10-24)27(26-6-2-4-23-5-3-13-30-28(23)26)22-11-14-33(15-12-22)18-25-19-36-20-31-25/h2-10,13,19-20,34H,11-12,14-18H2,1H3
InChIKey
ZJKUETLEJYCOBO-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Opioid receptor Target Info Modulator [550881]
References
Ref 522867ClinicalTrials.gov (NCT01020799) AZD7268 Safety and Tolerability Study. U.S. National Institutes of Health.
Ref 542769(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7824).
Ref 550881EP patent application no. 2774991, Drug delivery system for use in the treatment or diagnosis of neurological disorders.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.